UBS Group’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-600
| Closed | -$5.98K | – | 9934 |
|
|
2022
Q4 | $5.98K | Hold |
600
| – | – | ﹤0.01% | 7903 |
|
|
2022
Q3 | $6K | Buy |
600
+260
| +76% | +$2.6K | ﹤0.01% | 8029 |
|
|
2022
Q2 | $3K | Hold |
340
| – | – | ﹤0.01% | 8411 |
|
|
2022
Q1 | $3K | Hold |
340
| – | – | ﹤0.01% | 8500 |
|
|
2021
Q4 | $3K | Buy |
+340
| New | +$3K | ﹤0.01% | 8614 |
|
|
2021
Q2 | – | Sell |
-840
| Closed | -$8K | – | 8807 |
|
|
2021
Q1 | $8K | Buy |
+840
| New | +$8K | ﹤0.01% | 7080 |
|